Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01043627 · ClinicalTrials.gov registry record
Sildenafil to Tadalafil in Pulmonary Arterial Hypertension (SITAR)
A clinical trial, sponsored by Mayo Clinic.
- Completed
- Registry status
- 100
- Enrollment target
NCT01043627: Completed study, sponsored by Mayo Clinic.
NCT01043627 is a clinical trial that has completed, run by Mayo Clinic. The registered enrollment target is 100 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01043627 has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- 100 participants
- Enrollment target
Study Summary
Assess tolerability, transition methods and clinical effects of transition from sildenafil (Revatio) to tadalafil (Adcirca) for treatment of pulmonary arterial hypertension.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2009-12 |
| Est. Completion | 2011-12 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01043627
The ClinicalTrials.gov registry entry for NCT01043627 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 100 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT01043627 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01043627 about?
NCT01043627 is a clinical study titled "Sildenafil to Tadalafil in Pulmonary Arterial Hypertension (SITAR)". Assess tolerability, transition methods and clinical effects of transition from sildenafil (Revatio) to tadalafil (Adcirca) for treatment of pulmonary arterial hypertension.
What is the current status of trial NCT01043627?
This trial is currently completed. The enrollment target is 100 participants. The study started on 2009-12. Estimated completion is 2011-12.
Who is sponsoring clinical trial NCT01043627?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.